Clearance Summary
Avance Solo Negative Pressure Wound Therapy (NPWT) System received FDA 510(k) clearance under submission number K203369, sponsored by Molnlycke Health Care Us, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2021-07-01.
- Submission: K203369
- Applicant / Sponsor: Molnlycke Health Care Us, LLC
- Clearance pathway: Traditional
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4780
- Decision date: 2021-07-01
Classification & Regulation
This clearance is catalogued under FDA product code OMP and 21 CFR 878.4780, within the General, Plastic Surgery review panel as a Class II device.